nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—Cladribine—multiple sclerosis	0.585	1	CrCtD
Regadenoson—Clofarabine—Cladribine—multiple sclerosis	0.0581	0.164	CrCrCtD
Regadenoson—Fludarabine—Cladribine—multiple sclerosis	0.0545	0.154	CrCrCtD
Regadenoson—Adenosine monophosphate—Cladribine—multiple sclerosis	0.0513	0.145	CrCrCtD
Regadenoson—Nelarabine—Cladribine—multiple sclerosis	0.0513	0.145	CrCrCtD
Regadenoson—Azacitidine—Cladribine—multiple sclerosis	0.0461	0.13	CrCrCtD
Regadenoson—Adenosine—Cladribine—multiple sclerosis	0.0461	0.13	CrCrCtD
Regadenoson—Vidarabine—Cladribine—multiple sclerosis	0.0461	0.13	CrCrCtD
Regadenoson—S-Adenosylmethionine—SRM—multiple sclerosis	0.00149	0.479	CrCbGaD
Regadenoson—Clofarabine—RRM1—multiple sclerosis	0.000638	0.205	CrCbGaD
Regadenoson—Fludarabine—RRM1—multiple sclerosis	0.000618	0.199	CrCbGaD
Regadenoson—Cladribine—RRM1—multiple sclerosis	0.000366	0.118	CrCbGaD
Regadenoson—Angioedema—Methylprednisolone—multiple sclerosis	7.56e-05	0.0013	CcSEcCtD
Regadenoson—Abdominal discomfort—Methotrexate—multiple sclerosis	7.53e-05	0.0013	CcSEcCtD
Regadenoson—Erythema—Betamethasone—multiple sclerosis	7.52e-05	0.00129	CcSEcCtD
Regadenoson—Erythema—Dexamethasone—multiple sclerosis	7.52e-05	0.00129	CcSEcCtD
Regadenoson—Malaise—Triamcinolone—multiple sclerosis	7.48e-05	0.00129	CcSEcCtD
Regadenoson—Malaise—Methylprednisolone—multiple sclerosis	7.46e-05	0.00128	CcSEcCtD
Regadenoson—Syncope—Triamcinolone—multiple sclerosis	7.44e-05	0.00128	CcSEcCtD
Regadenoson—Syncope—Methylprednisolone—multiple sclerosis	7.42e-05	0.00128	CcSEcCtD
Regadenoson—Connective tissue disorder—Prednisone—multiple sclerosis	7.4e-05	0.00127	CcSEcCtD
Regadenoson—Feeling abnormal—Mitoxantrone—multiple sclerosis	7.39e-05	0.00127	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisolone—multiple sclerosis	7.36e-05	0.00127	CcSEcCtD
Regadenoson—Dizziness—Azathioprine—multiple sclerosis	7.34e-05	0.00126	CcSEcCtD
Regadenoson—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	7.34e-05	0.00126	CcSEcCtD
Regadenoson—Loss of consciousness—Triamcinolone—multiple sclerosis	7.29e-05	0.00125	CcSEcCtD
Regadenoson—Loss of consciousness—Methylprednisolone—multiple sclerosis	7.27e-05	0.00125	CcSEcCtD
Regadenoson—Shock—Prednisolone—multiple sclerosis	7.24e-05	0.00125	CcSEcCtD
Regadenoson—Cough—Triamcinolone—multiple sclerosis	7.24e-05	0.00124	CcSEcCtD
Regadenoson—Convulsion—Triamcinolone—multiple sclerosis	7.18e-05	0.00124	CcSEcCtD
Regadenoson—Tachycardia—Prednisolone—multiple sclerosis	7.18e-05	0.00124	CcSEcCtD
Regadenoson—Convulsion—Methylprednisolone—multiple sclerosis	7.17e-05	0.00123	CcSEcCtD
Regadenoson—Hypertension—Triamcinolone—multiple sclerosis	7.16e-05	0.00123	CcSEcCtD
Regadenoson—Hypertension—Methylprednisolone—multiple sclerosis	7.14e-05	0.00123	CcSEcCtD
Regadenoson—Urticaria—Mitoxantrone—multiple sclerosis	7.13e-05	0.00123	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisolone—multiple sclerosis	7.11e-05	0.00122	CcSEcCtD
Regadenoson—Abdominal pain—Mitoxantrone—multiple sclerosis	7.09e-05	0.00122	CcSEcCtD
Regadenoson—Myalgia—Triamcinolone—multiple sclerosis	7.06e-05	0.00121	CcSEcCtD
Regadenoson—Vomiting—Azathioprine—multiple sclerosis	7.06e-05	0.00121	CcSEcCtD
Regadenoson—Myalgia—Methylprednisolone—multiple sclerosis	7.04e-05	0.00121	CcSEcCtD
Regadenoson—Arthralgia—Methylprednisolone—multiple sclerosis	7.04e-05	0.00121	CcSEcCtD
Regadenoson—Eye disorder—Prednisone—multiple sclerosis	7.03e-05	0.00121	CcSEcCtD
Regadenoson—Anxiety—Methylprednisolone—multiple sclerosis	7.02e-05	0.00121	CcSEcCtD
Regadenoson—Rash—Azathioprine—multiple sclerosis	7e-05	0.0012	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	7e-05	0.0012	CcSEcCtD
Regadenoson—Dermatitis—Azathioprine—multiple sclerosis	6.99e-05	0.0012	CcSEcCtD
Regadenoson—Flushing—Prednisone—multiple sclerosis	6.99e-05	0.0012	CcSEcCtD
Regadenoson—Ill-defined disorder—Dexamethasone—multiple sclerosis	6.98e-05	0.0012	CcSEcCtD
Regadenoson—Ill-defined disorder—Betamethasone—multiple sclerosis	6.98e-05	0.0012	CcSEcCtD
Regadenoson—Discomfort—Triamcinolone—multiple sclerosis	6.98e-05	0.0012	CcSEcCtD
Regadenoson—Discomfort—Methylprednisolone—multiple sclerosis	6.96e-05	0.0012	CcSEcCtD
Regadenoson—Headache—Azathioprine—multiple sclerosis	6.95e-05	0.0012	CcSEcCtD
Regadenoson—Renal failure—Methotrexate—multiple sclerosis	6.89e-05	0.00118	CcSEcCtD
Regadenoson—Angioedema—Dexamethasone—multiple sclerosis	6.88e-05	0.00118	CcSEcCtD
Regadenoson—Angioedema—Betamethasone—multiple sclerosis	6.88e-05	0.00118	CcSEcCtD
Regadenoson—Angiopathy—Prednisone—multiple sclerosis	6.83e-05	0.00117	CcSEcCtD
Regadenoson—Immune system disorder—Prednisone—multiple sclerosis	6.8e-05	0.00117	CcSEcCtD
Regadenoson—Malaise—Betamethasone—multiple sclerosis	6.79e-05	0.00117	CcSEcCtD
Regadenoson—Malaise—Dexamethasone—multiple sclerosis	6.79e-05	0.00117	CcSEcCtD
Regadenoson—Anaphylactic shock—Triamcinolone—multiple sclerosis	6.77e-05	0.00116	CcSEcCtD
Regadenoson—Anaphylactic shock—Methylprednisolone—multiple sclerosis	6.75e-05	0.00116	CcSEcCtD
Regadenoson—Syncope—Betamethasone—multiple sclerosis	6.75e-05	0.00116	CcSEcCtD
Regadenoson—Syncope—Dexamethasone—multiple sclerosis	6.75e-05	0.00116	CcSEcCtD
Regadenoson—Shock—Triamcinolone—multiple sclerosis	6.66e-05	0.00115	CcSEcCtD
Regadenoson—Insomnia—Prednisolone—multiple sclerosis	6.66e-05	0.00114	CcSEcCtD
Regadenoson—Shock—Methylprednisolone—multiple sclerosis	6.64e-05	0.00114	CcSEcCtD
Regadenoson—Nervous system disorder—Methylprednisolone—multiple sclerosis	6.62e-05	0.00114	CcSEcCtD
Regadenoson—Loss of consciousness—Betamethasone—multiple sclerosis	6.61e-05	0.00114	CcSEcCtD
Regadenoson—Loss of consciousness—Dexamethasone—multiple sclerosis	6.61e-05	0.00114	CcSEcCtD
Regadenoson—Hypersensitivity—Mitoxantrone—multiple sclerosis	6.61e-05	0.00114	CcSEcCtD
Regadenoson—Paraesthesia—Prednisolone—multiple sclerosis	6.61e-05	0.00114	CcSEcCtD
Regadenoson—Tachycardia—Triamcinolone—multiple sclerosis	6.61e-05	0.00114	CcSEcCtD
Regadenoson—Mental disorder—Prednisone—multiple sclerosis	6.59e-05	0.00113	CcSEcCtD
Regadenoson—Nausea—Azathioprine—multiple sclerosis	6.59e-05	0.00113	CcSEcCtD
Regadenoson—Tachycardia—Methylprednisolone—multiple sclerosis	6.59e-05	0.00113	CcSEcCtD
Regadenoson—Skin disorder—Methylprednisolone—multiple sclerosis	6.56e-05	0.00113	CcSEcCtD
Regadenoson—Erythema—Prednisone—multiple sclerosis	6.55e-05	0.00113	CcSEcCtD
Regadenoson—Hyperhidrosis—Triamcinolone—multiple sclerosis	6.54e-05	0.00113	CcSEcCtD
Regadenoson—Hyperhidrosis—Methylprednisolone—multiple sclerosis	6.53e-05	0.00112	CcSEcCtD
Regadenoson—Convulsion—Betamethasone—multiple sclerosis	6.52e-05	0.00112	CcSEcCtD
Regadenoson—Convulsion—Dexamethasone—multiple sclerosis	6.52e-05	0.00112	CcSEcCtD
Regadenoson—Hypertension—Dexamethasone—multiple sclerosis	6.5e-05	0.00112	CcSEcCtD
Regadenoson—Hypertension—Betamethasone—multiple sclerosis	6.5e-05	0.00112	CcSEcCtD
Regadenoson—Asthenia—Mitoxantrone—multiple sclerosis	6.44e-05	0.00111	CcSEcCtD
Regadenoson—Myalgia—Dexamethasone—multiple sclerosis	6.41e-05	0.0011	CcSEcCtD
Regadenoson—Myalgia—Betamethasone—multiple sclerosis	6.41e-05	0.0011	CcSEcCtD
Regadenoson—Anxiety—Betamethasone—multiple sclerosis	6.38e-05	0.0011	CcSEcCtD
Regadenoson—Anxiety—Dexamethasone—multiple sclerosis	6.38e-05	0.0011	CcSEcCtD
Regadenoson—Discomfort—Dexamethasone—multiple sclerosis	6.33e-05	0.00109	CcSEcCtD
Regadenoson—Discomfort—Betamethasone—multiple sclerosis	6.33e-05	0.00109	CcSEcCtD
Regadenoson—Hypotension—Methylprednisolone—multiple sclerosis	6.31e-05	0.00109	CcSEcCtD
Regadenoson—Pain—Prednisolone—multiple sclerosis	6.29e-05	0.00108	CcSEcCtD
Regadenoson—Vision blurred—Prednisone—multiple sclerosis	6.18e-05	0.00106	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	6.17e-05	0.00106	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	6.15e-05	0.00106	CcSEcCtD
Regadenoson—Anaphylactic shock—Dexamethasone—multiple sclerosis	6.14e-05	0.00106	CcSEcCtD
Regadenoson—Anaphylactic shock—Betamethasone—multiple sclerosis	6.14e-05	0.00106	CcSEcCtD
Regadenoson—Diarrhoea—Mitoxantrone—multiple sclerosis	6.14e-05	0.00106	CcSEcCtD
Regadenoson—Insomnia—Triamcinolone—multiple sclerosis	6.12e-05	0.00105	CcSEcCtD
Regadenoson—Insomnia—Methylprednisolone—multiple sclerosis	6.11e-05	0.00105	CcSEcCtD
Regadenoson—Ill-defined disorder—Prednisone—multiple sclerosis	6.08e-05	0.00105	CcSEcCtD
Regadenoson—Paraesthesia—Triamcinolone—multiple sclerosis	6.08e-05	0.00105	CcSEcCtD
Regadenoson—Feeling abnormal—Prednisolone—multiple sclerosis	6.06e-05	0.00104	CcSEcCtD
Regadenoson—Paraesthesia—Methylprednisolone—multiple sclerosis	6.06e-05	0.00104	CcSEcCtD
Regadenoson—Shock—Dexamethasone—multiple sclerosis	6.04e-05	0.00104	CcSEcCtD
Regadenoson—Shock—Betamethasone—multiple sclerosis	6.04e-05	0.00104	CcSEcCtD
Regadenoson—Dyspnoea—Triamcinolone—multiple sclerosis	6.03e-05	0.00104	CcSEcCtD
Regadenoson—Nervous system disorder—Betamethasone—multiple sclerosis	6.02e-05	0.00104	CcSEcCtD
Regadenoson—Nervous system disorder—Dexamethasone—multiple sclerosis	6.02e-05	0.00104	CcSEcCtD
Regadenoson—Tachycardia—Betamethasone—multiple sclerosis	5.99e-05	0.00103	CcSEcCtD
Regadenoson—Tachycardia—Dexamethasone—multiple sclerosis	5.99e-05	0.00103	CcSEcCtD
Regadenoson—Angioedema—Prednisone—multiple sclerosis	5.99e-05	0.00103	CcSEcCtD
Regadenoson—Hyperhidrosis—Betamethasone—multiple sclerosis	5.94e-05	0.00102	CcSEcCtD
Regadenoson—Hyperhidrosis—Dexamethasone—multiple sclerosis	5.94e-05	0.00102	CcSEcCtD
Regadenoson—Malaise—Prednisone—multiple sclerosis	5.91e-05	0.00102	CcSEcCtD
Regadenoson—Eye disorder—Methotrexate—multiple sclerosis	5.88e-05	0.00101	CcSEcCtD
Regadenoson—Syncope—Prednisone—multiple sclerosis	5.88e-05	0.00101	CcSEcCtD
Regadenoson—Tinnitus—Methotrexate—multiple sclerosis	5.87e-05	0.00101	CcSEcCtD
Regadenoson—Urticaria—Prednisolone—multiple sclerosis	5.85e-05	0.00101	CcSEcCtD
Regadenoson—Cardiac disorder—Methotrexate—multiple sclerosis	5.84e-05	0.001	CcSEcCtD
Regadenoson—Pain—Triamcinolone—multiple sclerosis	5.79e-05	0.000995	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisone—multiple sclerosis	5.76e-05	0.00099	CcSEcCtD
Regadenoson—Hypotension—Betamethasone—multiple sclerosis	5.74e-05	0.000987	CcSEcCtD
Regadenoson—Hypotension—Dexamethasone—multiple sclerosis	5.74e-05	0.000987	CcSEcCtD
Regadenoson—Angiopathy—Methotrexate—multiple sclerosis	5.71e-05	0.000982	CcSEcCtD
Regadenoson—Vomiting—Mitoxantrone—multiple sclerosis	5.7e-05	0.000981	CcSEcCtD
Regadenoson—Immune system disorder—Methotrexate—multiple sclerosis	5.68e-05	0.000977	CcSEcCtD
Regadenoson—Convulsion—Prednisone—multiple sclerosis	5.68e-05	0.000976	CcSEcCtD
Regadenoson—Mediastinal disorder—Methotrexate—multiple sclerosis	5.67e-05	0.000975	CcSEcCtD
Regadenoson—Hypertension—Prednisone—multiple sclerosis	5.66e-05	0.000973	CcSEcCtD
Regadenoson—Rash—Mitoxantrone—multiple sclerosis	5.66e-05	0.000973	CcSEcCtD
Regadenoson—Dermatitis—Mitoxantrone—multiple sclerosis	5.65e-05	0.000972	CcSEcCtD
Regadenoson—Headache—Mitoxantrone—multiple sclerosis	5.62e-05	0.000966	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	5.59e-05	0.000962	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	5.59e-05	0.000962	CcSEcCtD
Regadenoson—Arthralgia—Prednisone—multiple sclerosis	5.58e-05	0.000959	CcSEcCtD
Regadenoson—Myalgia—Prednisone—multiple sclerosis	5.58e-05	0.000959	CcSEcCtD
Regadenoson—Feeling abnormal—Triamcinolone—multiple sclerosis	5.58e-05	0.000959	CcSEcCtD
Regadenoson—Feeling abnormal—Methylprednisolone—multiple sclerosis	5.56e-05	0.000957	CcSEcCtD
Regadenoson—Anxiety—Prednisone—multiple sclerosis	5.56e-05	0.000956	CcSEcCtD
Regadenoson—Insomnia—Betamethasone—multiple sclerosis	5.55e-05	0.000955	CcSEcCtD
Regadenoson—Insomnia—Dexamethasone—multiple sclerosis	5.55e-05	0.000955	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	5.54e-05	0.000953	CcSEcCtD
Regadenoson—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	5.52e-05	0.00095	CcSEcCtD
Regadenoson—Paraesthesia—Betamethasone—multiple sclerosis	5.51e-05	0.000948	CcSEcCtD
Regadenoson—Paraesthesia—Dexamethasone—multiple sclerosis	5.51e-05	0.000948	CcSEcCtD
Regadenoson—Discomfort—Prednisone—multiple sclerosis	5.51e-05	0.000948	CcSEcCtD
Regadenoson—Mental disorder—Methotrexate—multiple sclerosis	5.51e-05	0.000948	CcSEcCtD
Regadenoson—Erythema—Methotrexate—multiple sclerosis	5.48e-05	0.000942	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisolone—multiple sclerosis	5.42e-05	0.000932	CcSEcCtD
Regadenoson—Urticaria—Triamcinolone—multiple sclerosis	5.38e-05	0.000925	CcSEcCtD
Regadenoson—Urticaria—Methylprednisolone—multiple sclerosis	5.36e-05	0.000923	CcSEcCtD
Regadenoson—Dysgeusia—Methotrexate—multiple sclerosis	5.36e-05	0.000922	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisone—multiple sclerosis	5.35e-05	0.00092	CcSEcCtD
Regadenoson—Abdominal pain—Methylprednisolone—multiple sclerosis	5.34e-05	0.000918	CcSEcCtD
Regadenoson—Nausea—Mitoxantrone—multiple sclerosis	5.33e-05	0.000916	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Betamethasone—multiple sclerosis	5.3e-05	0.000912	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	5.3e-05	0.000912	CcSEcCtD
Regadenoson—Shock—Prednisone—multiple sclerosis	5.26e-05	0.000905	CcSEcCtD
Regadenoson—Pain—Betamethasone—multiple sclerosis	5.25e-05	0.000903	CcSEcCtD
Regadenoson—Pain—Dexamethasone—multiple sclerosis	5.25e-05	0.000903	CcSEcCtD
Regadenoson—Nervous system disorder—Prednisone—multiple sclerosis	5.24e-05	0.000902	CcSEcCtD
Regadenoson—Tachycardia—Prednisone—multiple sclerosis	5.22e-05	0.000898	CcSEcCtD
Regadenoson—Skin disorder—Prednisone—multiple sclerosis	5.19e-05	0.000893	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisone—multiple sclerosis	5.17e-05	0.000889	CcSEcCtD
Regadenoson—Vision blurred—Methotrexate—multiple sclerosis	5.16e-05	0.000888	CcSEcCtD
Regadenoson—Ill-defined disorder—Methotrexate—multiple sclerosis	5.08e-05	0.000874	CcSEcCtD
Regadenoson—Feeling abnormal—Dexamethasone—multiple sclerosis	5.06e-05	0.00087	CcSEcCtD
Regadenoson—Feeling abnormal—Betamethasone—multiple sclerosis	5.06e-05	0.00087	CcSEcCtD
Regadenoson—Gastrointestinal pain—Dexamethasone—multiple sclerosis	5.02e-05	0.000864	CcSEcCtD
Regadenoson—Gastrointestinal pain—Betamethasone—multiple sclerosis	5.02e-05	0.000864	CcSEcCtD
Regadenoson—Hypersensitivity—Triamcinolone—multiple sclerosis	4.99e-05	0.000858	CcSEcCtD
Regadenoson—Hypersensitivity—Methylprednisolone—multiple sclerosis	4.98e-05	0.000856	CcSEcCtD
Regadenoson—Malaise—Methotrexate—multiple sclerosis	4.94e-05	0.000849	CcSEcCtD
Regadenoson—Urticaria—Betamethasone—multiple sclerosis	4.88e-05	0.000839	CcSEcCtD
Regadenoson—Urticaria—Dexamethasone—multiple sclerosis	4.88e-05	0.000839	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Prednisone—multiple sclerosis	4.87e-05	0.000838	CcSEcCtD
Regadenoson—Dizziness—Prednisolone—multiple sclerosis	4.87e-05	0.000837	CcSEcCtD
Regadenoson—Asthenia—Triamcinolone—multiple sclerosis	4.86e-05	0.000835	CcSEcCtD
Regadenoson—Abdominal pain—Betamethasone—multiple sclerosis	4.85e-05	0.000835	CcSEcCtD
Regadenoson—Abdominal pain—Dexamethasone—multiple sclerosis	4.85e-05	0.000835	CcSEcCtD
Regadenoson—Asthenia—Methylprednisolone—multiple sclerosis	4.84e-05	0.000833	CcSEcCtD
Regadenoson—Insomnia—Prednisone—multiple sclerosis	4.84e-05	0.000832	CcSEcCtD
Regadenoson—Paraesthesia—Prednisone—multiple sclerosis	4.8e-05	0.000826	CcSEcCtD
Regadenoson—Cough—Methotrexate—multiple sclerosis	4.78e-05	0.000822	CcSEcCtD
Regadenoson—Convulsion—Methotrexate—multiple sclerosis	4.74e-05	0.000816	CcSEcCtD
Regadenoson—Arthralgia—Methotrexate—multiple sclerosis	4.66e-05	0.000802	CcSEcCtD
Regadenoson—Chest pain—Methotrexate—multiple sclerosis	4.66e-05	0.000802	CcSEcCtD
Regadenoson—Myalgia—Methotrexate—multiple sclerosis	4.66e-05	0.000802	CcSEcCtD
Regadenoson—Rash—Prednisolone—multiple sclerosis	4.64e-05	0.000798	CcSEcCtD
Regadenoson—Dermatitis—Prednisolone—multiple sclerosis	4.64e-05	0.000797	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	4.63e-05	0.000796	CcSEcCtD
Regadenoson—Diarrhoea—Methylprednisolone—multiple sclerosis	4.62e-05	0.000795	CcSEcCtD
Regadenoson—Headache—Prednisolone—multiple sclerosis	4.61e-05	0.000793	CcSEcCtD
Regadenoson—Discomfort—Methotrexate—multiple sclerosis	4.61e-05	0.000792	CcSEcCtD
Regadenoson—Dizziness—Triamcinolone—multiple sclerosis	4.48e-05	0.00077	CcSEcCtD
Regadenoson—Anaphylactic shock—Methotrexate—multiple sclerosis	4.47e-05	0.000769	CcSEcCtD
Regadenoson—Dizziness—Methylprednisolone—multiple sclerosis	4.47e-05	0.000768	CcSEcCtD
Regadenoson—Feeling abnormal—Prednisone—multiple sclerosis	4.41e-05	0.000758	CcSEcCtD
Regadenoson—Asthenia—Dexamethasone—multiple sclerosis	4.41e-05	0.000758	CcSEcCtD
Regadenoson—Asthenia—Betamethasone—multiple sclerosis	4.41e-05	0.000758	CcSEcCtD
Regadenoson—Nervous system disorder—Methotrexate—multiple sclerosis	4.38e-05	0.000754	CcSEcCtD
Regadenoson—Gastrointestinal pain—Prednisone—multiple sclerosis	4.37e-05	0.000752	CcSEcCtD
Regadenoson—Nausea—Prednisolone—multiple sclerosis	4.37e-05	0.000752	CcSEcCtD
Regadenoson—Skin disorder—Methotrexate—multiple sclerosis	4.34e-05	0.000747	CcSEcCtD
Regadenoson—Hyperhidrosis—Methotrexate—multiple sclerosis	4.32e-05	0.000743	CcSEcCtD
Regadenoson—Vomiting—Triamcinolone—multiple sclerosis	4.3e-05	0.00074	CcSEcCtD
Regadenoson—Vomiting—Methylprednisolone—multiple sclerosis	4.29e-05	0.000738	CcSEcCtD
Regadenoson—Rash—Triamcinolone—multiple sclerosis	4.27e-05	0.000734	CcSEcCtD
Regadenoson—Dermatitis—Triamcinolone—multiple sclerosis	4.26e-05	0.000733	CcSEcCtD
Regadenoson—Rash—Methylprednisolone—multiple sclerosis	4.26e-05	0.000732	CcSEcCtD
Regadenoson—Dermatitis—Methylprednisolone—multiple sclerosis	4.25e-05	0.000732	CcSEcCtD
Regadenoson—Urticaria—Prednisone—multiple sclerosis	4.25e-05	0.000731	CcSEcCtD
Regadenoson—Headache—Triamcinolone—multiple sclerosis	4.24e-05	0.000729	CcSEcCtD
Regadenoson—Headache—Methylprednisolone—multiple sclerosis	4.23e-05	0.000728	CcSEcCtD
Regadenoson—Abdominal pain—Prednisone—multiple sclerosis	4.23e-05	0.000727	CcSEcCtD
Regadenoson—Diarrhoea—Betamethasone—multiple sclerosis	4.2e-05	0.000723	CcSEcCtD
Regadenoson—Diarrhoea—Dexamethasone—multiple sclerosis	4.2e-05	0.000723	CcSEcCtD
Regadenoson—Hypotension—Methotrexate—multiple sclerosis	4.18e-05	0.000718	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	4.07e-05	0.0007	CcSEcCtD
Regadenoson—Dizziness—Dexamethasone—multiple sclerosis	4.06e-05	0.000698	CcSEcCtD
Regadenoson—Dizziness—Betamethasone—multiple sclerosis	4.06e-05	0.000698	CcSEcCtD
Regadenoson—Insomnia—Methotrexate—multiple sclerosis	4.04e-05	0.000695	CcSEcCtD
Regadenoson—Nausea—Triamcinolone—multiple sclerosis	4.02e-05	0.000691	CcSEcCtD
Regadenoson—Paraesthesia—Methotrexate—multiple sclerosis	4.01e-05	0.00069	CcSEcCtD
Regadenoson—Nausea—Methylprednisolone—multiple sclerosis	4.01e-05	0.00069	CcSEcCtD
Regadenoson—Dyspnoea—Methotrexate—multiple sclerosis	3.98e-05	0.000685	CcSEcCtD
Regadenoson—Somnolence—Methotrexate—multiple sclerosis	3.97e-05	0.000683	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisone—multiple sclerosis	3.94e-05	0.000678	CcSEcCtD
Regadenoson—Vomiting—Dexamethasone—multiple sclerosis	3.9e-05	0.000671	CcSEcCtD
Regadenoson—Vomiting—Betamethasone—multiple sclerosis	3.9e-05	0.000671	CcSEcCtD
Regadenoson—Rash—Betamethasone—multiple sclerosis	3.87e-05	0.000666	CcSEcCtD
Regadenoson—Rash—Dexamethasone—multiple sclerosis	3.87e-05	0.000666	CcSEcCtD
Regadenoson—Dermatitis—Betamethasone—multiple sclerosis	3.87e-05	0.000665	CcSEcCtD
Regadenoson—Dermatitis—Dexamethasone—multiple sclerosis	3.87e-05	0.000665	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Methotrexate—multiple sclerosis	3.86e-05	0.000664	CcSEcCtD
Regadenoson—Headache—Dexamethasone—multiple sclerosis	3.85e-05	0.000662	CcSEcCtD
Regadenoson—Headache—Betamethasone—multiple sclerosis	3.85e-05	0.000662	CcSEcCtD
Regadenoson—Asthenia—Prednisone—multiple sclerosis	3.84e-05	0.00066	CcSEcCtD
Regadenoson—Pain—Methotrexate—multiple sclerosis	3.82e-05	0.000657	CcSEcCtD
Regadenoson—Feeling abnormal—Methotrexate—multiple sclerosis	3.68e-05	0.000633	CcSEcCtD
Regadenoson—Diarrhoea—Prednisone—multiple sclerosis	3.66e-05	0.000629	CcSEcCtD
Regadenoson—Gastrointestinal pain—Methotrexate—multiple sclerosis	3.65e-05	0.000629	CcSEcCtD
Regadenoson—Nausea—Betamethasone—multiple sclerosis	3.65e-05	0.000627	CcSEcCtD
Regadenoson—Nausea—Dexamethasone—multiple sclerosis	3.65e-05	0.000627	CcSEcCtD
Regadenoson—Urticaria—Methotrexate—multiple sclerosis	3.55e-05	0.000611	CcSEcCtD
Regadenoson—Dizziness—Prednisone—multiple sclerosis	3.54e-05	0.000608	CcSEcCtD
Regadenoson—Abdominal pain—Methotrexate—multiple sclerosis	3.53e-05	0.000608	CcSEcCtD
Regadenoson—Vomiting—Prednisone—multiple sclerosis	3.4e-05	0.000585	CcSEcCtD
Regadenoson—Rash—Prednisone—multiple sclerosis	3.37e-05	0.00058	CcSEcCtD
Regadenoson—Dermatitis—Prednisone—multiple sclerosis	3.37e-05	0.000579	CcSEcCtD
Regadenoson—Headache—Prednisone—multiple sclerosis	3.35e-05	0.000576	CcSEcCtD
Regadenoson—Hypersensitivity—Methotrexate—multiple sclerosis	3.29e-05	0.000566	CcSEcCtD
Regadenoson—Asthenia—Methotrexate—multiple sclerosis	3.21e-05	0.000551	CcSEcCtD
Regadenoson—Nausea—Prednisone—multiple sclerosis	3.18e-05	0.000546	CcSEcCtD
Regadenoson—Diarrhoea—Methotrexate—multiple sclerosis	3.06e-05	0.000526	CcSEcCtD
Regadenoson—Dizziness—Methotrexate—multiple sclerosis	2.96e-05	0.000508	CcSEcCtD
Regadenoson—Vomiting—Methotrexate—multiple sclerosis	2.84e-05	0.000489	CcSEcCtD
Regadenoson—Rash—Methotrexate—multiple sclerosis	2.82e-05	0.000485	CcSEcCtD
Regadenoson—Dermatitis—Methotrexate—multiple sclerosis	2.82e-05	0.000484	CcSEcCtD
Regadenoson—Headache—Methotrexate—multiple sclerosis	2.8e-05	0.000482	CcSEcCtD
Regadenoson—Nausea—Methotrexate—multiple sclerosis	2.65e-05	0.000457	CcSEcCtD
